Skip to main content
. Author manuscript; available in PMC: 2020 Nov 1.
Published in final edited form as: Cytokine. 2019 Jul 22;123:154776. doi: 10.1016/j.cyto.2019.154776

Fig. 6. Effect of STAT1, STAT3 or JAK/STAT inhibitor on the expression of ISGs and tight junction proteins in End1/E6E7 cells.

Fig. 6.

End1/E6E7 cells were treated with or without JAK inhibitor (JAK Inh), STAT1 inhibitor (Fludarabine) or STAT3 inhibitor (Stattic) for 1h and then incubated with IL-22 for additional 12 h. Cellular proteins were subjected to Western blot assay using the antibodies to the ISGs and the TJs.